Temperature Controlled Packaging for Pharmaceutical Market Research Report Information By Product (Insulated Shippers, and Insulated Containers), By Type (Active Systems, and Passive Systems), By Temperature Range (Up to 10 C, 10 C to 20 C, and More than 20 C), By End-Use Industry (Pharmaceutical, and Clinical Trail), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS

1.1.1 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET BY PRODUCT

1.1.2 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE

1.1.3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE

1.1.4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY

1.1.5 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE

1.1.6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE

1.1.7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS

3.2 PRIMARY RESEARCH

3.3 SECONDARY RESEARCH

3.4 MARKET SIZE ESTIMATION

3.5 TOP-DOWN AND BOTTOM-UP APPROACH

3.6 FORECAST MODEL

3.7 LIST OF ASSUMPTIONS

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY SUPPLEMENTING SALES TO THE SIGNIFICANT EXTENT

4.2.2 ADOPTION OF SMARTER COLD CHAIN TECHNOLOGY

4.2.3 DRIVER IMPACT ANALYSIS

4.3 RESTRAINTS

4.3.1 RISE IN RAW MATERIAL COSTS

4.3.2 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITY

4.4.1 VARIOUS GOVERNMENT INITIATIVES ARE CARRIED OUT BY VARIOUS COUNTRIES TO BOOST THE PHARMACEUTICAL INDUSTRY

4.4.2 INCREASE IN R & D INVESTMENT IN THE PHARMACEUTICAL INDUSTRY OFFERING REVENUE-GENERATING OPPORTUNITIES

4.4.3 SUSTAINABILITY AND PHARMACEUTICAL TEMPERATURE CONTROL PACKAGING

4.5 IMPACT OF COVID-19 ANALYSIS

4.5.1 ECONOMIC IMPACT

4.5.1.1 IMPACT ON THE PACKAGING INDUSTRY

4.5.2 IMPACT ON PRODUCTION

4.5.3 IMPACT ON TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY

4.5.3.1 IMPACT ON SUPPLY CHAIN

4.5.3.2 IMPACT ON RAW MATERIALS

4.5.3.3 CASH FLOW CONSTRAINTS

4.5.4 IMPACT ON WORLD TRADE

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL

5.1.1 THREAT OF NEW ENTRANTS

5.1.2 BARGAINING POWER OF SUPPLIERS

5.1.3 THREAT OF SUBSTITUTES

5.1.4 BARGAINING POWER OF BUYERS

5.1.5 INTENSITY OF RIVALRY

5.2 SUPPLY CHAIN ANALYSIS

5.2.1 DESIGN AND DEVELOPMENT

5.2.2 RAW MATERIAL SUPPLY

5.2.3 MANUFACTURER

5.2.4 DISTRIBUTION

5.2.5 END-USERS

6 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 SHIPPERS

6.3 CONTAINERS

7 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE

7.1 OVERVIEW

7.2 ACTIVE SYSTEM

7.3 PASSIVE SYSTEM

8 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE

8.1 OVERVIEW

8.2 -20°C AND BELOW

8.3 -20°C TO -10°C

8.4 - 10°C TO 10°C

8.5 10°C TO 20°C

8.6 ABOVE 20°C

9 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY

9.1 OVERVIEW

9.2 UP TO 10 L

9.3 10 L - 20 L

9.4 20 L - 40 L

9.5 40 L - 150 L

9.6 ABOVE 150 L

10 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE

10.1 OVERVIEW

10.2 SINGLE USE

10.3 REUSABLE

11 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE

11.1 OVERVIEW

11.2 TEMPERATURE SENSITIVE PHARMACEUTICAL DRUGS

11.3 VACCINE

11.4 REGENERATIVE MEDICINE

12 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY

12.1 OVERVIEW

12.2 PHARMACEUTICALS

12.3 CLINICAL TRAILS

13 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION

13.1 OVERVIEW

13.1.1 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018–2030

13.2 NORTH AMERICA

13.2.1 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030

13.2.2 US

13.2.3 CANADA

13.3 EUROPE

13.3.1 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030

13.3.2 GERMANY

13.3.3 FRANCE

13.3.4 UK

13.3.5 ITALY

13.3.6 SPAIN

13.3.7 REST OF EUROPE

13.4 ASIA PACIFIC

13.4.1 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030

13.4.2 CHINA

13.4.3 JAPAN

13.4.4 INDIA

13.4.5 SOUTH KOREA

13.4.6 TAIWAN

13.4.7 PHILIPPINES

13.4.8 INDONESIA

13.4.9 THAILAND

13.4.10 MALAYSIA

13.4.11 SINGAPORE

13.4.12 HONG KONG

13.4.13 AUSTRALIA

13.4.14 REST OF APAC

13.5 REST OF WORLD

13.5.1 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030

13.5.2 MIDDLE EAST & AFRICA

13.5.3 SOUTH AMERICA

14 COMPETITIVE LANDSCAPE

14.1 OVERVIEW

14.2 COMPETITIVE BENCHMARKING

14.3 MARKET SHARE ANALYSIS

14.4 KEY DEVELOPMENTS IN THE GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET

14.4.1 ACQUISITION

14.4.2 EXPANSION

14.4.3 PARTNERSHIP/AGREEMANT

14.4.4 PRODUCT LAUNCH/PRODUCT APPROVAL

14.4.5 PRODUCT DEVELOPMENT

14.4.6 COLLABORATION

15 COMPANY PROFILES

15.1 COLD CHAIN TECHNOLOGIES, LLC

15.1.1 COMPANY OVERVIEW

15.1.2 FINANCIAL OVERVIEW

15.1.3 PRODUCTS OFFERED

15.1.4 KEY DEVELOPMENTS

15.1.5 SWOT ANALYSIS

15.1.6 KEY STRATEGIES

15.2 EMBALL’ISO

15.2.1 COMPANY OVERVIEW

15.2.2 FINANCIAL OVERVIEW

15.2.3 PRODUCTS OFFERED

15.2.4 KEY DEVELOPMENTS

15.2.5 SWOT ANALYSIS

15.2.6 KEY STRATEGIES

15.3 INMARK, LLC

15.3.1 COMPANY OVERVIEW

15.3.2 FINANCIAL OVERVIEW

15.3.3 PRODUCTS OFFERED

15.3.4 KEY DEVELOPMENTS

15.3.5 SWOT ANALYSIS

15.3.6 KEY STRATEGIES

15.4 SONOCO THERMOSAFE

15.4.1 COMPANY OVERVIEW

15.4.2 FINANCIAL OVERVIEW

15.4.3 PRODUCTS OFFERED

15.4.4 KEY DEVELOPMENTS

15.4.5 SWOT ANALYSIS

15.4.6 KEY STRATEGIES

15.5 VA-Q-TEC AG

15.5.1 COMPANY OVERVIEW

15.5.2 FINANCIAL OVERVIEW

15.5.3 PRODUCTS OFFERED

15.5.4 KEY DEVELOPMENTS

15.5.5 SWOT ANALYSIS

15.5.6 KEY STRATEGIES

15.6 DEUTSCHE BAHN AG

15.6.1 COMPANY OVERVIEW

15.6.2 FINANCIAL OVERVIEW

15.6.3 PRODUCTS OFFERED

15.6.4 KEY DEVELOPMENTS

15.6.5 SWOT ANALYSIS

15.6.6 KEY STRATEGIES

15.7 DHL INTERNATIONAL GMBH

15.7.1 COMPANY OVERVIEW

15.7.2 FINANCIAL OVERVIEW

15.7.3 PRODUCTS OFFERED

15.7.4 KEY DEVELOPMENTS

15.7.5 SWOT ANALYSIS

15.7.6 KEY STRATEGIES

15.8 KUEHNE + NAGEL INC.

15.8.1 COMPANY OVERVIEW

15.8.2 FINANCIAL OVERVIEW

15.8.3 PRODUCTS OFFERED

15.8.4 KEY DEVELOPMENTS

15.8.5 SWOT ANALYSIS

15.8.6 KEY STRATEGIES

15.9 UNITED PARCEL SERVICE OF AMERICA, INC.

15.9.1 COMPANY OVERVIEW

15.9.2 FINANCIAL OVERVIEW

15.9.3 PRODUCTS OFFERED

15.9.4 KEY DEVELOPMENTS

15.9.5 SWOT ANALYSIS

15.9.6 KEY STRATEGIES

15.10 KANEKA CORPORATION

15.10.1 COMPANY OVERVIEW

15.10.2 FINANCIAL OVERVIEW

15.10.3 PRODUCTS OFFERED

15.10.4 KEY DEVELOPMENTS

15.10.5 SWOT ANALYSIS

15.10.6 KEY STRATEGIES

15.11 CSAFE GLOBAL

15.11.1 COMPANY OVERVIEW

15.11.2 FINANCIAL OVERVIEW

15.11.3 PRODUCTS OFFERED

15.11.4 KEY DEVELOPMENTS

15.11.5 SWOT ANALYSIS

15.11.6 KEY STRATEGIES

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS

TABLE 2 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT 2018–2030 (USD MILLION)

TABLE 3 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 4 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 5 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 6 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 7 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 8 REGENERATIVE MEDICINE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 9 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 10 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 11 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 12 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 13 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 14 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 15 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 16 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 17 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 18 REGENERATIVE MEDICINE: NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 19 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 20 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 21 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 22 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 23 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 24 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 25 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 26 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 27 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 28 CANADATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 29 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 30 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 31 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 32 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 33 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 34 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 35 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 36 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 37 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 38 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 39 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 40 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 41 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 42 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 43 REGENERATIVE MEDICINE: EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 44 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 45 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 46 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 47 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 48 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 49 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 50 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 51 REGENERATIVE MEDICINE: GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 52 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 53 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 54 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 55 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 56 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 57 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 58 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 59 REGENERATIVE MEDICINE: FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 60 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 61 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 62 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 63 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 64 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 65 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 66 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 67 REGENERATIVE MEDICINE: UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 68 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 69 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 70 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 71 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 72 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 73 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 74 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 75 REGENERATIVE MEDICINE: ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 76 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 77 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 78 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 79 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 80 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 81 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 82 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 83 REGENERATIVE MEDICINE: SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 84 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 85 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 86 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 87 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 88 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 89 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 90 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 91 REGENERATIVE MEDICINE: REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 92 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 93 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 94 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 95 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 96 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 97 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 98 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 99 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 100 REGENERATIVE MEDICINE: ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 101 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 102 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 103 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 104 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 105 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 106 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 107 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 108 REGENERATIVE MEDICINE: CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 109 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 110 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 111 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 112 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 113 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 114 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 115 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 116 REGENERATIVE MEDICINE: JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 117 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 118 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 119 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 120 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 121 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 122 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 123 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 124 REGENERATIVE MEDICINE: INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 125 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 126 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 127 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 128 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 129 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 130 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 131 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 132 REGENERATIVE MEDICINE: SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 133 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 134 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 135 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 136 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 137 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 138 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 139 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 140 REGENERATIVE MEDICINE: TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 141 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 142 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 143 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 144 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 145 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 146 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 147 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 148 REGENERATIVE MEDICINE: PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 149 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 150 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 151 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 152 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 153 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 154 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 155 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 156 REGENERATIVE MEDICINE: INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 157 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 158 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 159 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 160 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 161 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 162 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 163 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 164 REGENERATIVE MEDICINE: THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 165 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 166 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 167 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 168 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 169 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 170 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 171 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 172 REGENERATIVE MEDICINE: MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 173 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 174 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 175 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 176 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 177 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 178 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 179 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 180 REGENERATIVE MEDICINE: SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 181 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 182 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 183 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 184 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 185 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 186 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 187 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 188 REGENERATIVE MEDICINE: HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 189 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 190 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 191 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 192 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 193 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 194 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 195 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 196 REGENERATIVE MEDICINE: AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 197 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 198 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 199 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 200 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 201 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 202 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 203 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 204 REGENERATIVE MEDICINE: REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 205 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 206 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 207 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 208 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 209 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 210 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 211 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 212 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 213 REGENERATIVE MEDICINE: REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 214 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 215 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 216 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 217 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 218 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 219 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 220 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 221 REGENERATIVE MEDICINE: MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 222 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 223 SOUTH AMERICATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 224 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 225 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)

TABLE 226 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)

TABLE 227 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)

TABLE 228 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 229 REGENERATIVE MEDICINE: SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)

TABLE 230 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)

TABLE 231 ACQUISITION

TABLE 232 EXPANSION

TABLE 233 PARTNERSHIP/AGREEMENT

TABLE 234 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 235 PRODUCT DEVELOPMENT

TABLE 236 COLLABORATION

TABLE 237 COLD CHAIN TECHNOLOGIES, LLC: PRODUCTS OFFERED

TABLE 238 COLD CHAIN TECHNOLOGIES, LLC: KEY DEVELOPMENTS

TABLE 239 EMBALL’ISO: PRODUCTS OFFERED

TABLE 240 INMARK INC: PRODUCTS OFFERED

TABLE 241 SONOCO THERMOSAFE: PRODUCTS OFFERED

TABLE 242 SONOCO THERMOSAFE: KEY DEVELOPMENTS

TABLE 243 VA-Q-TEC AG: PRODUCTS OFFERED

TABLE 244 VA-Q-TEC AG: KEY DEVELOPMENTS

TABLE 245 DEUTSCHE BAHN AG: PRODUCTS OFFERED

TABLE 246 DHL INTERNATIONAL GMBH: PRODUCTS OFFERED

TABLE 247 DHL INTERNATIONAL GMBH: KEY DEVELOPMENTS

TABLE 248 KUEHNE + NAGEL INC.: PRODUCTS OFFERED

TABLE 249 KUEHNE + NAGEL INC.: KEY DEVELOPMENTS

TABLE 250 UNITED PARCEL SERVICE OF AMERICA, INC.: PRODUCTS OFFERED

TABLE 251 UNITED PARCEL SERVICE OF AMERICA, INC.: KEY DEVELOPMENTS

TABLE 252 KANEKA CORPORATION: PRODUCTS OFFERED

TABLE 253 KANEKA CORPORATION: KEY DEVELOPMENTS

TABLE 254 CSAFE GLOBAL: PRODUCTS OFFERED

TABLE 255 CSAFE GLOBAL: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PRODUCT

FIGURE 3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TYPE

FIGURE 4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TEMPERATURE RANGE

FIGURE 5 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PAYLOAD CAPACITY

FIGURE 6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY USE

FIGURE 7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY MEDICINE TYPE

FIGURE 8 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS BY END USE INDUSTRY

FIGURE 9 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET: MARKET STRUCTURE

FIGURE 10 RESEARCH PROCESS OF MRFR

FIGURE 11 MARKET DYNAMICS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET

FIGURE 12 DRIVER IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET

FIGURE 13 RESTRAINT IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET

FIGURE 14 PORTER’S FIVE FORCES ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET

FIGURE 15 SUPPLY CHAIN ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET

FIGURE 16 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2021 (% SHARE)

FIGURE 17 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

FIGURE 18 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2021 (% SHARE)

FIGURE 19 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2018–2030 (USD MILLION)

FIGURE 20 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2021 (% SHARE)

FIGURE 21 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2018–2030 (USD MILLION)

FIGURE 22 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2021 (% SHARE)

FIGURE 23 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2018–2030 (USD MILLION)

FIGURE 24 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2021 (% SHARE)

FIGURE 25 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2018–2030 (USD MILLION)

FIGURE 26 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2021 (% SHARE)

FIGURE 27 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2018–2030 (USD MILLION)

FIGURE 28 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2021 (% SHARE)

FIGURE 29 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2018–2030 (USD MILLION)

FIGURE 30 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2021 (% SHARE)

FIGURE 31 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018-2027

FIGURE 32 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)

FIGURE 33 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)

FIGURE 34 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)

FIGURE 35 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)

FIGURE 36 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 37 MARKET SHARE ANALYSIS, 2021

FIGURE 38 COLD CHAIN TECHNOLOGIES, LLC: SWOT ANALYSIS

FIGURE 39 EMBALL’ISO: SWOT ANALYSIS

FIGURE 40 INMARK, LLC: SWOT ANALYSIS

FIGURE 41 SONOCO THERMOSAFE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 SONOCO THERMOSAFE: SWOT ANALYSIS

FIGURE 43 VA-Q-TEC AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 44 VA-Q-TEC AG: SWOT ANALYSIS

FIGURE 45 DEUTSCHE BAHN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 DEUTSCHE BAHN AG: SWOT ANALYSIS

FIGURE 47 DHL INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 48 DHL INTERNATIONAL GMBH: SWOT ANALYSIS

FIGURE 49 KUEHNE + NAGEL INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 50 KUEHNE + NAGEL INC.: SWOT ANALYSIS

FIGURE 51 UNITED PARCEL SERVICE OF AMERICA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 52 UNITED PARCEL SERVICE OF AMERICA, INC.: SWOT ANALYSIS

FIGURE 53 KANEKA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 54 KANEKA CORPORATION: SWOT ANALYSIS

FIGURE 55 CSAFE GLOBAL: SWOT ANALYSIS